WIN 55,212-2 MESYLATE

WIN 55,212-2 MESYLATE Struktur
1308285-21-3
CAS-Nr.
1308285-21-3
Englisch Name:
WIN 55,212-2 MESYLATE
Synonyma:
5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one methanesulfonate
CBNumber:
CB92538694
Summenformel:
C23H34N6O7S2
Molgewicht:
570.68
MOL-Datei:
1308285-21-3.mol

WIN 55,212-2 MESYLATE Eigenschaften

storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
Löslichkeit
≥57.1 mg/mL in DMSO; insoluble in EtOH; ≥25.95 mg/mL in H2O
Aggregatzustand
solid

Sicherheit

WIN 55,212-2 MESYLATE Chemische Eigenschaften,Einsatz,Produktion Methoden

WIN 55,212-2 MESYLATE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


WIN 55,212-2 MESYLATE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 58)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
career henan chemical co
+86-0371-86658258 +8613203830695
sales@coreychem.com China 29881 58
Hubei xin bonus chemical co. LTD
86-13657291602
linda@hubeijusheng.com CHINA 22963 58
Chongqing Chemdad Co., Ltd
+86-023-6139-8061 +86-86-13650506873
sales@chemdad.com China 39894 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 32165 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6312 58
changzhou huayang technology co., ltd
+8615250961469
2571773637@qq.com China 9725 58
TargetMol Chemicals Inc.

support@targetmol.com United States 38632 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 57505 58
Guangzhou Dihao Medical Technology Co., Ltd 18602015453
2667751176@qq.com China 485 58
Shandong longtai fine chemical co., ltd 15169750147
1908452573@qq.com China 49 58

1308285-21-3()Verwandte Suche:


  • 5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one methanesulfonate
  • 1308285-21-3
  • C23H34N6O7S2
Copyright 2019 © ChemicalBook. All rights reserved